Neuroprotective effects of brain‐derived neurotrophic factor against amyloid beta 1‐40‐induced retinal and optic nerve damage

Abstract

Brain‐derived neurotrophic factor (BDNF) could be considered a potential neuroprotective therapy in amyloid beta (Aβ)‐associated retinal and optic nerve degeneration. Hence, in this study we investigated the neuroprotective effect of BDNF against Aβ1‐40‐induced retinal and optic nerve injury. In this study, exposure to Aβ1‐40 was associated with retinal and optic nerve injury. TUNEL staining showed significant reduction in the apoptotic cell count in the BDNF‐treated group compared with Aβ1‐40 group. H&E‐stained retinal sections also showed a striking reduction in neuronal cells in the ganglion cell layer (GCL) of retinas fourteen days after Aβ1‐40 exposure. By contrast, number of retinal cells was preserved in the retinas of BDNF‐treated animals. After Aβ1‐40 exposure, visible axonal swelling was observed in optic nerve sections. However, the BDNF‐treated group showed fewer changes in optic nerve; axonal swelling was less frequent and less marked. In the present study, exposure to Aβ was associated with oxidative stress, whereas levels of retinal glutathione (GSH), superoxide dismutase (SOD) and catalase were significantly increased in BDNF‐treated than in Aβ1‐40‐treated rats. Both visual object recognition tests using an open‐field arena and a Morris water maze showed that BDNF improved rats’ ability to recognise visual cues (objects with different shapes) after Aβ1‐40 exposure, thus demonstrating that the visual performance of rats was relatively preserved following BDNF treatment. In conclusion, intravitreal treatment with BDNF prevents Aβ1‐40‐induced retinal cell apoptosis and axon loss in the optic nerve of rats by reducing retinal oxidative stress and restoring retinal BDNF levels.